Miller D - Search Results

1

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.

Scolding N, Barnes D, Cader S, Chataway J, Chaudhuri A, Coles A, Giovannoni G, Miller D, Rashid W, Schmierer K, Shehu A, Silber E, Young C, Zajicek J. Scolding N, et al. Among authors: miller d. Pract Neurol. 2015 Aug;15(4):273-9. doi: 10.1136/practneurol-2015-001139. Epub 2015 Jun 22. Pract Neurol. 2015. PMID: 26101071 No abstract available.

2

Recent advances in neuroimaging of multiple sclerosis.

Rashid W, Miller DH. Rashid W, et al. Semin Neurol. 2008 Feb;28(1):46-55. doi: 10.1055/s-2007-1019127. Semin Neurol. 2008. PMID: 18256986 Review.

3

Multiple sclerosis-quenching the flames of inflammation.

Chataway J, Miller DH. Chataway J, et al. Lancet. 2011 Nov 19;378(9805):1759-60. doi: 10.1016/S0140-6736(11)61133-1. Epub 2011 Oct 31. Lancet. 2011. PMID: 22047970 No abstract available.

4

Natalizumab therapy for multiple sclerosis.

Chataway J, Miller DH. Chataway J, et al. Neurotherapeutics. 2013 Jan;10(1):19-28. doi: 10.1007/s13311-012-0171-4. Neurotherapeutics. 2013. PMID: 23307290 Free PMC article. Review.

5

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.

Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Cano MG, McManus D, Mallik S, Hobart J; CUPID investigator group. Zajicek J, et al. Among authors: miller d. Lancet Neurol. 2013 Sep;12(9):857-865. doi: 10.1016/S1474-4422(13)70159-5. Epub 2013 Jul 13. Lancet Neurol. 2013. PMID: 23856559 Free PMC article. Review.

6

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

Kapoor R, Furby J, Hayton T, Smith KJ, Altmann DR, Brenner R, Chataway J, Hughes RA, Miller DH. Kapoor R, et al. Lancet Neurol. 2010 Jul;9(7):681-8. doi: 10.1016/S1474-4422(10)70131-9. Epub 2010 Jun 8. Lancet Neurol. 2010. PMID: 20621711 Clinical Trial.

7

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA. Coles AJ, et al. Among authors: miller dh. J Neurol. 2006 Jan;253(1):98-108. doi: 10.1007/s00415-005-0934-5. Epub 2005 Jul 27. J Neurol. 2006. PMID: 16044212

8

Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis.

Karrenbauer VD, Leoni V, Lim ET, Giovannoni G, Ingle GT, Sastre-Garriga J, Thompson AJ, Rashid W, Davies G, Miller DH, Björkhem I, Masterman T. Karrenbauer VD, et al. Clin Neurol Neurosurg. 2006 Jul;108(5):456-60. doi: 10.1016/j.clineuro.2005.07.010. Epub 2005 Sep 6. Clin Neurol Neurosurg. 2006. PMID: 16144738

9

Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging.

Rashid W, Hadjiprocopis A, Davies G, Griffin C, Chard D, Tiberio M, Altmann D, Wheeler-Kingshott C, Tozer D, Thompson A, Miller DH. Rashid W, et al. Among authors: miller dh. J Neurol. 2008 Mar;255(3):390-7. doi: 10.1007/s00415-008-0678-0. Epub 2008 Mar 20. J Neurol. 2008. PMID: 18350361

10

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain.

Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Schmierer K, et al. Ann Neurol. 2004 Sep;56(3):407-15. doi: 10.1002/ana.20202. Ann Neurol. 2004. PMID: 15349868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,635 results

Search Page

Filters